Long COVID Patterns in the RECOVER-Adult Study
November 21, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Fanapt
Synonyms :
iloperidone
Class :
Antipsychotics, 2nd Generation
Brand Name :
Fanapt
Synonyms :
iloperidone
Class :
Antipsychotics, 2nd Generation
Dosage forms & Strengths:Â
TabletÂ
1 mgÂ
2 mgÂ
4 mgÂ
6 mgÂ
8 mgÂ
10 mgÂ
12 mgÂ
Take a dose of 6 to 12 mg orally two times daily
Increase the dose gradually as and when required
Take a dose of 12 mg orally two times daily
Increase the dose gradually as and when required
Safety and efficacy are not seen in pediatricsÂ
may enhance the serum concentration of CYP3A4 inhibitors
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
may diminish the anti-neoplastic activity of corticosteroids
they decrease the concentration of active metabolites of iloperidone in the serum
they decrease the concentration of active metabolites of iloperidone in the serum
they decrease the concentration of active metabolites of iloperidone in the serum
they decrease the concentration of active metabolites of iloperidone in the serum
they decrease the concentration of active metabolites of iloperidone in the serum
when both drugs are combined, there may be an increased risk or severity of QTC prolongation  
QTc interval is increased both by lenvatinib and iloperidone
may increase the QTc interval when combined
may enhance the hypotensive effect of Blood Pressure Lowering Agents
may enhance the hypotensive effect of Blood Pressure Lowering Agents
may enhance the hypotensive effect of Blood Pressure Lowering Agents
may enhance the hypotensive effect of Blood Pressure Lowering Agents
may enhance the hypotensive effect of Blood Pressure Lowering Agents
thrombolytic Agents may enhance the adverse/toxic effect of prostacyclin Analogues
may enhance the adverse/toxic effect of anticoagulants
may enhance the adverse/toxic effect of anticoagulants
may enhance the adverse/toxic effect of anticoagulants
may enhance the adverse/toxic effect of anticoagulants
may enhance the adverse/toxic effect of anticoagulants
may have an increased antiplatelet effect when combined with antiplatelet agents
may have an increased antiplatelet effect when combined with antiplatelet agents
may have an increased antiplatelet effect when combined with antiplatelet agents
may have an increased antiplatelet effect when combined with antiplatelet agents
may have an increased antiplatelet effect when combined with antiplatelet agents
may have an increased adverse effect when combined with anticoagulants
may have an increased adverse effect when combined with anticoagulants
may have an increased adverse effect when combined with anticoagulants
may have an increased adverse effect when combined with anticoagulants
may have an increased adverse effect when combined with anticoagulants
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased hypotensive effect when combined with anti-hypertensive agents
may have an increased adverse effect when combined with prostacyclin analogues
It may enhance sedation when combined with a shepherd's purse
It may diminish the effects when combined with chasteberry by pharmacodynamic antagonism
may have an increased hypotensive effect when combined with antihypertensive drugs
prostacyclin analogues: they may increase the hypotensive effect when combined with blood viscosity-reducing agents
prostacyclin analogues: they may increase the hypotensive effect when combined with blood viscosity-reducing agents
prostacyclin: they may increase the antiplatelet effect of antiplatelet agents
prostacyclin: they may increase the antiplatelet effect of antiplatelet agents
may have an increased antiplatelet effect when combined with antiplatelet agents
may have an increased antiplatelet effect when combined with antiplatelet agents
it increases the effect or level of palbociclib by altering the intestinal or hepatic CYP3A4 enzyme metabolism
may increase the level of effectiveness through P-glycoprotein MDR1 efflux transporter
relugolix/​estradiol/​norethindroneÂ
it decreases by affecting the hepatic enzyme CYP3A4 metabolism
may increase the hypotensive effect of antihypertensives
may enhance the toxic effect of anti-coagulants
may increase the hypotensive effect of calcium channel blockers
may increase the hypotensive effect of calcium channel blockers
lisinopril/hydrochlorothiazideÂ
may increase the hypotensive effect of blood pressure-lowering agents
eprosartan/hydrochlorothiazideÂ
may increase the hypotensive effect of blood pressure-lowering agents
valsartan/hydrochlorothiazideÂ
may increase the hypotensive effect of blood pressure-lowering agents
may increase the antiplatelet effect of antiplatelet agents
may have an increased hypotensive effect when combined with antihypertensive agents
may have an increased hypotensive effect when combined with antihypertensive agents
may have an increased hypotensive effect when combined with antihypertensive agents
may have an increased hypotensive effect when combined with antihypertensive agents
may have an increased hypotensive effect when combined with antihypertensive agents
may increase the hypotensive effect of Blood Pressure Lowering Agents
may increase the hypotensive effect of Blood Pressure Lowering Agents
may increase the hypotensive effect of Blood Pressure Lowering Agents
may decrease the hypotensive effect of Blood Pressure Lowering Agents
It may diminish the metabolism when combined with Heparins
It may diminish the metabolism when combined with Heparins
It may diminish the metabolism when combined with Heparins
may have an increasingly adverse effect when combined with prostacyclin analogues
When iloperidone is used together in combination with profenamine, this leads to reduction in therapeutic effectiveness of profenamine
>10%:Â
Dizziness Â
Dry mouthÂ
Nausea Â
Somnolence Â
TachycardiaÂ
1-10%:Â
Ejaculation failureÂ
DiarrheaÂ
MyalgiaÂ
PalpitationsÂ
Nasal congestionÂ
Weight gainÂ
Urinary incontinenceÂ
<1%:Â
EdemaÂ
AmenorrheaÂ
HypothyroidismÂ
Frequency undefined:Â
PriapismÂ
Iloperidone is contraindicated in patients hypersensitive to the active ingredient.Â
Pregnancy consideration:Â Â
Category CÂ
Breastfeeding warnings:Â Â
No data is available regarding the excretion of the drug in breast milk.Â
Pregnancy category:Â
Patient information leafletÂ
Generic Name: iloperidoneÂ
Pronounced: ilo-PER-i-doneÂ
Why do we use iloperidone?Â
Iloperidone is a second-generation antipsychotic. It is used to reverse the effect of general anesthesia. It is used to treat schizophrenia.Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
